Macrocyclics, Inc. is a leading manufacturer of customized chelating agents, specializing in the development of innovative chelation chemistry platforms for diagnostic and therapeutic medicine. With a history dating back to 1995, the company offers advanced solutions in the field of nuclear medicine, including site-specific bioconjugation, peptide intermediates, and cutting-edge chelating agent technology.
Macrocyclics also provides comprehensive services such as cGMP manufacturing, technical support for catalog products, custom synthesis, contract manufacturing, and project consultation. With a commitment to molecular innovation for medicine, Macrocyclics continues to be at the forefront of providing advanced chelating technology to the healthcare industry.
Generated from the website